{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:04:08Z","timestamp":1785200648979,"version":"3.55.0"},"reference-count":167,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Telethon-UILDM Foundation","award":["GUP19012"],"award-info":[{"award-number":["GUP19012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Alterations in the DMD gene, which codes for the protein dystrophin, cause forms of dystrophinopathies such as Duchenne muscular dystrophy, an X-linked disease. Cardiomyopathy linked to DMD mutations is becoming the leading cause of death in patients with dystrophinopathy. Since phenotypic pathophysiological mechanisms are not fully understood, the improvement and development of new disease models, considering their relative advantages and disadvantages, is essential. The application of genetic engineering approaches on induced pluripotent stem cells, such as gene-editing technology, enables the development of physiologically relevant human cell models for in vitro dystrophinopathy studies. The combination of induced pluripotent stem cells-derived cardiovascular cell types and 3D bioprinting technologies hold great promise for the study of dystrophin-linked cardiomyopathy. This combined approach enables the assessment of responses to physical or chemical stimuli, and the influence of pharmaceutical approaches. The critical objective of in vitro microphysiological systems is to more accurately reproduce the microenvironment observed in vivo. Ground-breaking methodology involving the connection of multiple microphysiological systems comprised of different tissues would represent a move toward precision body-on-chip disease modelling could lead to a critical expansion in what is known about inter-organ responses to disease and novel therapies that have the potential to replace animal models. In this review, we will focus on the generation, development, and application of current cellular, animal, and potential for bio-printed models, in the study of the pathophysiological mechanisms underlying dystrophin-linked cardiomyopathy in the direction of personalized medicine.<\/jats:p>","DOI":"10.1093\/cvr\/cvab232","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T19:25:02Z","timestamp":1625685902000},"page":"1872-1884","source":"Crossref","is-referenced-by-count":12,"title":["Focus on the road to modelling cardiomyopathy in muscular dystrophy"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-4548","authenticated-orcid":false,"given":"Francesco","family":"Canonico","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Largo A. Gemelli 8 , 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-7993","authenticated-orcid":false,"given":"Maila","family":"Chirivi","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Cell Biology, National Research Council of Italy (IBBC-CNR) , Monterotondo , Rome, Italy"},{"name":"Istituto Nazionale Genetica Molecolare (INGM) \u201cRomeo ed Enrica Invernizzi\u201d , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-0031","authenticated-orcid":false,"given":"Fabio","family":"Maiullari","sequence":"additional","affiliation":[{"name":"Istituto Nazionale Genetica Molecolare (INGM) \u201cRomeo ed Enrica Invernizzi\u201d , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Milan","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Cell Biology, National Research Council of Italy (IBBC-CNR) , Monterotondo , Rome, Italy"},{"name":"Istituto Nazionale Genetica Molecolare (INGM) \u201cRomeo ed Enrica Invernizzi\u201d , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rizzi","sequence":"additional","affiliation":[{"name":"Istituto Nazionale Genetica Molecolare (INGM) \u201cRomeo ed Enrica Invernizzi\u201d , Milan , Italy"},{"name":"Institute of Biomedical Technologies, National Research Council of Italy (ITB-CNR) , Segrate, Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Arcudi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Largo A. Gemelli 8 , 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3909-182X","authenticated-orcid":false,"given":"Mattia","family":"Galli","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Largo A. Gemelli 8 , 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[{"name":"Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1098-3357","authenticated-orcid":false,"given":"Aoife","family":"Gowran","sequence":"additional","affiliation":[{"name":"Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-5735","authenticated-orcid":false,"given":"Giulio","family":"Pompilio","sequence":"additional","affiliation":[{"name":"Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS , Milan , Italy"},{"name":"Department of Biomedical, Surgical and Dental Sciences, University of Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[{"name":"Department of Women, Children and Public Health Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-411X","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Largo A. Gemelli 8 , 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bearzi","sequence":"additional","affiliation":[{"name":"Istituto Nazionale Genetica Molecolare (INGM) \u201cRomeo ed Enrica Invernizzi\u201d , Milan , Italy"},{"name":"Institute of Genetic and Biomedical Research, National Research Council (IRGB-CNR) , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D\u2019Amario","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS , Largo A. Gemelli 8 , 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"2022062819311138600_cvab232-B1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, andgastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"2022062819311138600_cvab232-B2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis","volume":"15","author":"Crisafulli","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2022062819311138600_cvab232-B3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","article-title":"Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)","volume":"155","author":"Ciafaloni","year":"2009","journal-title":"J Pediatr"},{"key":"2022062819311138600_cvab232-B4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ncl.2014.05.002","article-title":"Duchenne and Becker muscular dystrophies","volume":"32","author":"Flanigan","year":"2014","journal-title":"Neurol Clin"},{"key":"2022062819311138600_cvab232-B5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.healun.2009.08.030","article-title":"Clinical outcomes after cardiac transplantation in muscular dystrophy patients","volume":"29","author":"Wu","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2022062819311138600_cvab232-B6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jtcvs.2016.08.016","article-title":"Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: midterm results","volume":"153","author":"Perri","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022062819311138600_cvab232-B7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ehf2.12286","article-title":"Comment on: \u2018Implantation of a left ventricular assist device to provide long term support for end-stage Duchenne muscular dystrophy-associated cardiomyopathy\u2019 by Stoller et al","volume":"5","author":"Adorisio","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2022062819311138600_cvab232-B8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/heartjnl-2017-311269","article-title":"A current approach to heart failure in Duchenne muscular dystrophy","volume":"103","author":"D'Amario","year":"2017","journal-title":"Heart"},{"key":"2022062819311138600_cvab232-B9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2169\/internalmedicine.49.3259","article-title":"Carvedilol can prevent cardiac events in Duchenne muscular dystrophy","volume":"49","author":"Matsumura","year":"2010","journal-title":"Intern Med"},{"key":"2022062819311138600_cvab232-B10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"key":"2022062819311138600_cvab232-B11","doi-asserted-by":"crossref","first-page":"1756286419833478","DOI":"10.1177\/1756286419833478","article-title":"Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies","volume":"12","author":"Piga","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"2022062819311138600_cvab232-B12","first-page":"3","volume-title":"Bentham eBooks","author":"","year":"2017"},{"key":"2022062819311138600_cvab232-B13","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.3390\/ijms20174098","article-title":"Cardiac pathophysiology and the future of cardiac therapies in duchenne muscular dystrophy","volume":"20","author":"Meyers","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2022062819311138600_cvab232-B14","doi-asserted-by":"crossref","first-page":"e12063","DOI":"10.15252\/emmm.202012063","article-title":"Trans-generational epigenetic regulation associated with the amelioration of Duchenne Muscular Dystrophy","volume":"12","author":"Martone","year":"2020","journal-title":"EMBO Mol Med"},{"key":"2022062819311138600_cvab232-B15","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/mt.2010.123","article-title":"Exon skipping and Duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping","volume":"18","author":"Incitti","year":"2010","journal-title":"Mol Ther"},{"key":"2022062819311138600_cvab232-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","article-title":"Pathophysiology of Duchenne muscular dystrophy: current hypotheses","volume":"36","author":"Deconinck","year":"2007","journal-title":"Pediatric Neurology"},{"key":"2022062819311138600_cvab232-B17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cvr\/cvw204","article-title":"The nuclear pore protein Nup153 associates with chromatin and regulates cardiac gene expression in dystrophic mdx hearts","volume":"112","author":"Nanni","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2022062819311138600_cvab232-B18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0192623315609688","article-title":"Tailored pig models for preclinical efficacy and safety testing of targeted therapies","volume":"44","author":"Klymiuk","year":"2016","journal-title":"Toxicol Pathol"},{"key":"2022062819311138600_cvab232-B19","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1038\/s41598-018-22936-z","article-title":"Successful knock-in of hypertrophic cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs","volume":"8","author":"Montag","year":"2018","journal-title":"Sci Rep"},{"key":"2022062819311138600_cvab232-B20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/cr.2011.70","article-title":"Generation of PPAR\u03b3 mono-allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning","volume":"21","author":"Yang","year":"2011","journal-title":"Cell Res"},{"key":"2022062819311138600_cvab232-B21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/cvr\/cvz109","article-title":"Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells","volume":"116","author":"Pioner","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2022062819311138600_cvab232-B22","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0960-9822(00)00691-6","article-title":"Genetipionc suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans","volume":"10","author":"Gieseler","year":"2000","journal-title":"Curr Biol"},{"key":"2022062819311138600_cvab232-B23","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.036137","article-title":"Muscle strength deficiency and mitochondrial dysfunction in a muscular dystrophy model of Caenorhabditis elegans and its functional response to drugs","author":"Hewitt","year":"2018","journal-title":"Dis Models Mech"},{"key":"2022062819311138600_cvab232-B24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nmd.2004.02.011","article-title":"Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans","volume":"14","author":"Gaud","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"2022062819311138600_cvab232-B25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1474-9726.2008.00367.x","article-title":"Dystrophin deficiency in Drosophila reduces lifespan and causes a dilated cardiomyopathy phenotype","volume":"7","author":"Taghli-Lamallem","year":"2008","journal-title":"Aging Cell"},{"key":"2022062819311138600_cvab232-B26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ydbio.2011.01.013","article-title":"Stress and muscular dystrophy: a genetic screen for dystroglycan and dystrophin interactors in drosophila identifies cellular stress response components","volume":"352","author":"Kucherenko","year":"2011","journal-title":"Dev Biol"},{"key":"2022062819311138600_cvab232-B27","doi-asserted-by":"crossref","first-page":"e2418","DOI":"10.1371\/journal.pone.0002418","article-title":"Genetic modifier screens reveal new components that interact with the Drosophila dystroglycan-dystrophin complex","volume":"3","author":"Kucherenko","year":"2008","journal-title":"PLoS One"},{"key":"2022062819311138600_cvab232-B28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1152\/physiolgenomics.00088.2016","article-title":"Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy","volume":"48","author":"Widrick","year":"2016","journal-title":"Physiol Genomics"},{"key":"2022062819311138600_cvab232-B29","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: a point mutation","volume":"244","author":"Sicinski","year":"1989","journal-title":"Science (New York, N.Y.)"},{"key":"2022062819311138600_cvab232-B30","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1073\/pnas.0710595105","article-title":"Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency","volume":"105","author":"Khairallah","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022062819311138600_cvab232-B31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/mus.21763","article-title":"Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy","volume":"42","author":"Bostick","year":"2010","journal-title":"Muscle Nerve"},{"key":"2022062819311138600_cvab232-B32","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/hmg\/ddi197","article-title":"Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium","volume":"14","author":"Wehling-Henricks","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2022062819311138600_cvab232-B33","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1091\/mbc.01-09-0446","article-title":"Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle","volume":"13","author":"Rybakova","year":"2002","journal-title":"Mol Biol Cell"},{"key":"2022062819311138600_cvab232-B34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"2022062819311138600_cvab232-B35","doi-asserted-by":"crossref","first-page":"H2373","DOI":"10.1152\/ajpheart.00448.2005","article-title":"Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice","volume":"289","author":"Janssen","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022062819311138600_cvab232-B36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","article-title":"Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy","volume":"238","author":"Araki","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"2022062819311138600_cvab232-B37","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1073\/pnas.86.4.1292","article-title":"Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice","volume":"86","author":"Chapman","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022062819311138600_cvab232-B38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jpm8040041","article-title":"Multiple exon skipping in the duchenne muscular dystrophy hot spots: prospects and challenges","volume":"8","author":"Echigoya","year":"2018","journal-title":"J Pers Med"},{"key":"2022062819311138600_cvab232-B39","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci Adv"},{"key":"2022062819311138600_cvab232-B40","doi-asserted-by":"crossref","first-page":"e0193289","DOI":"10.1371\/journal.pone.0193289","article-title":"A dystrophic duchenne mouse model for testing human antisense oligonucleotides","volume":"13","author":"Veltrop","year":"2018","journal-title":"PLoS One"},{"key":"2022062819311138600_cvab232-B41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JND-170218","article-title":"Creation of a novel humanized dystrophic mouse model of Duchenne muscular dystrophy and application of a CRISPR\/Cas9 gene editing therapy","volume":"4","author":"Young","year":"2017","journal-title":"J Neuromuscul Dis"},{"key":"2022062819311138600_cvab232-B42","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1074\/jbc.M709410200","article-title":"Generation and characterization of transgenic mice with the full-length human DMD gene","volume":"283","author":"'t Hoen","year":"2008","journal-title":"J Biol Chem"},{"key":"2022062819311138600_cvab232-B43","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1096\/fj.201802488R","article-title":"Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy","volume":"33","author":"van Putten","year":"2019","journal-title":"FASEB J"},{"key":"2022062819311138600_cvab232-B44","doi-asserted-by":"crossref","first-page":"13763","DOI":"10.1073\/pnas.1204638109","article-title":"Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery","volume":"109","author":"Aoki","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022062819311138600_cvab232-B45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.12-219907","article-title":"Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases","volume":"27","author":"M\u00e9noret","year":"2013","journal-title":"FASEB J"},{"key":"2022062819311138600_cvab232-B46","doi-asserted-by":"crossref","first-page":"e110371","DOI":"10.1371\/journal.pone.0110371","article-title":"Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy","volume":"9","author":"Larcher","year":"2014","journal-title":"PLoS One"},{"key":"2022062819311138600_cvab232-B47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nbt.2661","article-title":"Heritable gene targeting in the mouse and rat using a CRISPR-Cas system","volume":"31","author":"Li","year":"2013","journal-title":"Nat Biotechnol"},{"key":"2022062819311138600_cvab232-B48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1536\/ihj.20-372","article-title":"Age-dependent echocardiographic and pathologic findings in a rat model with duchenne muscular dystrophy generated by CRISPR\/Cas9 genome editing","volume":"61","author":"Sugihara","year":"2020","journal-title":"Int Heart J"},{"key":"2022062819311138600_cvab232-B49","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.032201","article-title":"A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR\/Cas9","volume":"11","author":"Sui","year":"2018","journal-title":"Dis Model Mech"},{"key":"2022062819311138600_cvab232-B50","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1093\/hmg\/ddv120","article-title":"Functional disruption of the dystrophin gene in rhesus monkey using CRISPR\/Cas9","volume":"24","author":"Chen","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2022062819311138600_cvab232-B51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.omtm.2020.05.012","article-title":"rAAV8 and rAAV9-mediated long-term muscle transduction with tacrolimus (FK506) in non-human primates","volume":"18","author":"Ishii","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2022062819311138600_cvab232-B52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13395-017-0124-z","article-title":"The golden retriever model of Duchenne muscular dystrophy","volume":"7","author":"Kornegay","year":"2017","journal-title":"Skelet Muscle"},{"key":"2022062819311138600_cvab232-B53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/334154a0","article-title":"The homologue of the duchenne locus is defective in X-linked muscular dystrophy of dogs","volume":"334","author":"Cooper","year":"1988","journal-title":"Nature"},{"key":"2022062819311138600_cvab232-B54","first-page":"671","article-title":"Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model","volume":"135","author":"Valentine","year":"1989","journal-title":"Am J Pathol"},{"key":"2022062819311138600_cvab232-B55","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0735-1097(10)80202-5","article-title":"Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies","volume":"17","author":"Moise","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"2022062819311138600_cvab232-B56","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.ehj.2004.09.007","article-title":"Tissue Doppler imaging detects early asymptomatic myocardial abnormalities in a dog model of Duchenne's cardiomyopathy","volume":"25","author":"Chetboul","year":"2004","journal-title":"Eur Heart J"},{"key":"2022062819311138600_cvab232-B57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2011.03.010","article-title":"Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs","volume":"21","author":"Fine","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"2022062819311138600_cvab232-B58","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.rvsc.2012.09.027","article-title":"Cardiac structure and function in female carriers of a canine model of Duchenne muscular dystrophy","volume":"94","author":"Kane","year":"2013","journal-title":"Res Vet Sci"},{"key":"2022062819311138600_cvab232-B59","doi-asserted-by":"crossref","first-page":"e012443","DOI":"10.1161\/JAHA.119.012443","article-title":"Natural history of cardiomyopathy in adult dogs with golden retriever muscular dystrophy","volume":"8","author":"Guo","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2022062819311138600_cvab232-B60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2022062819311138600_cvab232-B61","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/hmg\/ddt287","article-title":"Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle","volume":"22","author":"Klymiuk","year":"2013","journal-title":"Hum Mol Genet"},{"key":"2022062819311138600_cvab232-B62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","article-title":"Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy","volume":"26","author":"Moretti","year":"2020","journal-title":"Nat Med"},{"key":"2022062819311138600_cvab232-B63","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.3390\/ijms21124354","article-title":"Modeling cardiac disease mechanisms using induced pluripotent stem cell-derived cardiomyocytes: progress, promises and challenges","volume":"21","author":"Parrotta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2022062819311138600_cvab232-B64","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/mt.2012.188","article-title":"Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation","volume":"20","author":"Goudenege","year":"2012","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"2022062819311138600_cvab232-B65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/7651_2015_257","article-title":"Directed myogenic differentiation of human induced pluripotent stem cells","volume":"1353","author":"Shoji","year":"2016","journal-title":"Methods Mol Biol"},{"key":"2022062819311138600_cvab232-B66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JND-190423","article-title":"Improved criteria for the classification of titin variants in inherited skeletal myopathies","volume":"7","author":"Savarese","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"2022062819311138600_cvab232-B67","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.stem.2009.04.001","article-title":"A small molecule primes embryonic stem cells for differentiation","volume":"4","author":"Zhu","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2022062819311138600_cvab232-B68","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/nbt.3297","article-title":"Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy","volume":"33","author":"Chal","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2022062819311138600_cvab232-B69","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3390\/cells9061527","article-title":"Extracellular vesicles from skeletal muscle cells efficiently promote myogenesis in induced pluripotent stem cells","volume":"9","author":"Baci","year":"2020","journal-title":"Cells"},{"key":"2022062819311138600_cvab232-B70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.scr.2018.01.025","article-title":"Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 \u039445-55)","volume":"28","author":"Gowran","year":"2018","journal-title":"Stem Cell Res"},{"key":"2022062819311138600_cvab232-B71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1242\/dmm.019505","article-title":"Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy","volume":"8","author":"Lin","year":"2015","journal-title":"Dis Model Mech"},{"key":"2022062819311138600_cvab232-B72","doi-asserted-by":"crossref","first-page":"4287158","DOI":"10.1155\/2016\/4287158","article-title":"Young at heart: pioneering approaches to model nonischaemic cardiomyopathy with induced pluripotent stem cells","volume":"2016","author":"Gowran","year":"2016","journal-title":"Stem Cells Int"},{"key":"2022062819311138600_cvab232-B73","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.3390\/ijms21196997","article-title":"\u201cBetwixt Mine Eye and Heart a League Is Took\u201d: the progress of induced pluripotent stem-cell-based models of dystrophin-associated cardiomyopathy","volume":"21","author":"Rovina","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2022062819311138600_cvab232-B74","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/cvr\/cvy208","article-title":"Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential","volume":"114","author":"van Mil","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2022062819311138600_cvab232-B75","doi-asserted-by":"crossref","first-page":"16519","DOI":"10.1038\/s41598-018-34879-6","article-title":"Exosomes exert cardioprotection in dystrophin-deficient cardiomyocytes via ERK1\/2-p38\/MAPK signaling","volume":"8","author":"Gartz","year":"2018","journal-title":"Sci Rep"},{"key":"2022062819311138600_cvab232-B76","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.045559","article-title":"Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy","volume":"13","author":"Gartz","year":"2020","journal-title":"Dis Model Mech"},{"key":"2022062819311138600_cvab232-B77","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/jcmm.14124","article-title":"Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients","volume":"23","author":"Eisen","year":"2019","journal-title":"J Cell Mol Med"},{"key":"2022062819311138600_cvab232-B78","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jacc.2019.12.066","article-title":"Stem cell-derived cardiomyocytes and beta-adrenergic receptor blockade in Duchenne muscular dystrophy cardiomyopathy","volume":"75","author":"Kamdar","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022062819311138600_cvab232-B79","first-page":"e000043","article-title":"Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine: a scientific statement from the American Heart Association","volume":"11","author":"Musunuru","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"2022062819311138600_cvab232-B80","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ymthe.2018.02.026","article-title":"Pluripotent stem cell-derived cardiomyocytes as a platform for cell therapy applications: progress and hurdles for clinical translation","volume":"26","author":"Oikonomopoulos","year":"2018","journal-title":"Mol Ther"},{"key":"2022062819311138600_cvab232-B81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12015-019-09935-x","article-title":"Advances in pluripotent stem cells: history, mechanisms, technologies, and applications","volume":"16","author":"Liu","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"2022062819311138600_cvab232-B82","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nbt.3816","article-title":"Highly efficient RNA-guided base editing in mouse embryos","volume":"35","author":"Kim","year":"2017","journal-title":"Nat Biotechnol"},{"key":"2022062819311138600_cvab232-B83","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci Transl Med"},{"key":"2022062819311138600_cvab232-B84","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1038\/s41467-019-12335-x","article-title":"In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse","volume":"10","author":"Amoasii","year":"2019","journal-title":"Nat Commun"},{"key":"2022062819311138600_cvab232-B85","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s10038-017-0400-0","article-title":"A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR\/Cas9 and evaluation of antisense-mediated exon skipping","volume":"63","author":"Shimo","year":"2018","journal-title":"J Hum Genet"},{"key":"2022062819311138600_cvab232-B86","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.csbj.2020.03.012","article-title":"Effective restoration of dystrophin expression in iPSC Mdx-derived muscle progenitor cells using the CRISPR\/Cas9 system and homology-directed repair technology","volume":"18","author":"Jin","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"2022062819311138600_cvab232-B87","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/genes11030342","article-title":"CRISPR-generated animal models of duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2020","journal-title":"Genes (Basel)"},{"key":"2022062819311138600_cvab232-B88","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.035774","article-title":"Tracking progress: an update on animal models for Duchenne muscular dystrophy","volume":"11","author":"Wells","year":"2018","journal-title":"Dis Model Mech"},{"key":"2022062819311138600_cvab232-B89","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jamacardio.2017.1713","article-title":"The hope and hype of CRISPR-Cas9 genome editing: a review","volume":"2","author":"Musunuru","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2022062819311138600_cvab232-B90","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat Commun"},{"key":"2022062819311138600_cvab232-B91","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-020-14957-y","article-title":"Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping","volume":"11","author":"Gee","year":"2020","journal-title":"Nat Commun"},{"key":"2022062819311138600_cvab232-B92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41434-020-0156-6","article-title":"Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy","volume":"27","author":"Dzierlega","year":"2020","journal-title":"Gene Ther"},{"key":"2022062819311138600_cvab232-B93","doi-asserted-by":"crossref","first-page":"eaan0713","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci Transl Med"},{"key":"2022062819311138600_cvab232-B94","first-page":"213","article-title":"Eteplirsen treatment attenuates respiratory decline in ambulatory and non-ambulatory patients with duchenne muscular dystrophy","author":"Khan","year":"2019"},{"key":"2022062819311138600_cvab232-B95","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1038\/s41467-018-06206-0","article-title":"Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies","volume":"9","author":"Antoury","year":"2018","journal-title":"Nat Commun"},{"key":"2022062819311138600_cvab232-B96","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s43440-020-00134-x","article-title":"Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future","volume":"72","author":"\u0141oboda","year":"2020","journal-title":"Pharmacol Rep"},{"key":"2022062819311138600_cvab232-B97","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14712598.2020.1725469","article-title":"Clinical development on the frontier: gene therapy for duchenne muscular dystrophy","volume":"20","author":"Asher","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"2022062819311138600_cvab232-B98","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41467-018-08283-7","article-title":"Next-generation muscle-directed gene therapy by in silico vector design","volume":"10","author":"Sarcar","year":"2019","journal-title":"Nat Commun"},{"key":"2022062819311138600_cvab232-B99","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1083\/jcb.201603111","article-title":"A human in vitro model of Duchenne muscular dystrophy muscle formation and contractility","volume":"215","author":"Nesmith","year":"2016","journal-title":"J Cell Biol"},{"key":"2022062819311138600_cvab232-B100","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aap9004","article-title":"Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing","volume":"4","author":"Long","year":"2018","journal-title":"Sci Adv"},{"key":"2022062819311138600_cvab232-B101","doi-asserted-by":"crossref","first-page":"e1701498","DOI":"10.1002\/adhm.201701498","article-title":"In vitro tissue-engineered skeletal muscle models for studying muscle physiology and disease","volume":"7","author":"Khodabukus","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"2022062819311138600_cvab232-B102","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/hum.1997.8.12-1429","article-title":"Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy","volume":"8","author":"Decary","year":"1997","journal-title":"Hum Gene Ther"},{"key":"2022062819311138600_cvab232-B103","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0146-0005(96)80064-4","article-title":"The heart and development","volume":"20","author":"Anderson","year":"1996","journal-title":"Semin Perinatol"},{"key":"2022062819311138600_cvab232-B104","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1177\/1535370214538589","article-title":"Physiology and metabolism of tissue-engineered skeletal muscle","volume":"239","author":"Cheng","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"key":"2022062819311138600_cvab232-B105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41592-019-0353-7","article-title":"Scalable analysis of cell-type composition from single-cell transcriptomics using deep recurrent learning","volume":"16","author":"Deng","year":"2019","journal-title":"Nat Methods"},{"key":"2022062819311138600_cvab232-B106","doi-asserted-by":"crossref","first-page":"eaba2619","DOI":"10.1126\/sciadv.aba2619","article-title":"Deep learning-based cell composition analysis from tissue expression profiles","volume":"6","author":"Menden","year":"2020","journal-title":"Sci Adv"},{"key":"2022062819311138600_cvab232-B107","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/jcm7090291","article-title":"Dystrophin cardiomyopathies: clinical management, molecular pathogenesis and evolution towards precision medicine","volume":"7","author":"D\u2019Amario","year":"2018","journal-title":"J Clin Med"},{"key":"2022062819311138600_cvab232-B108","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.20931","article-title":"Drug-screening platform based on the contractility of tissue-engineered muscle","volume":"37","author":"Vandenburgh","year":"2008","journal-title":"Muscle Nerve"},{"key":"2022062819311138600_cvab232-B109","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1096\/fj.09-134411","article-title":"Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts","volume":"23","author":"Vandenburgh","year":"2009","journal-title":"FASEB J"},{"key":"2022062819311138600_cvab232-B110","doi-asserted-by":"crossref","first-page":"e04885","DOI":"10.7554\/eLife.04885","article-title":"Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs","volume":"4","author":"Madden","year":"2015","journal-title":"Elife"},{"key":"2022062819311138600_cvab232-B111","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41467-017-02636-4","article-title":"Engineering human pluripotent stem cells into a functional skeletal muscle tissue","volume":"9","author":"Rao","year":"2018","journal-title":"Nat Commun"},{"key":"2022062819311138600_cvab232-B112","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/ten.tec.2008.0286","article-title":"Regulating fibrinolysis to engineer skeletal muscle from the C2C12 cell line","volume":"15","author":"Khodabukus","year":"2009","journal-title":"Tissue Eng Part C Methods"},{"key":"2022062819311138600_cvab232-B113","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.bioactmat.2020.10.021","article-title":"Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration","volume":"6","author":"Liu","year":"2020","journal-title":"Bioact Mater"},{"key":"2022062819311138600_cvab232-B114","doi-asserted-by":"crossref","first-page":"13532","DOI":"10.1038\/s41598-018-31848-x","article-title":"A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytes","volume":"8","author":"Maiullari","year":"2018","journal-title":"Sci Rep"},{"key":"2022062819311138600_cvab232-B115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","article-title":"Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease","volume":"26","author":"Giacomelli","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2022062819311138600_cvab232-B116","doi-asserted-by":"crossref","first-page":"185101","DOI":"10.1088\/1361-6528\/aaafa1","article-title":"3D bioprinting mesenchymal stem cell-laden construct with core-shell nanospheres for cartilage tissue engineering","volume":"29","author":"Zhu","year":"2018","journal-title":"Nanotechnology"},{"key":"2022062819311138600_cvab232-B117","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biomaterials.2018.04.034","article-title":"Human stem cell based corneal tissue mimicking structures using laser-assisted 3D bioprinting and functional bioinks","volume":"171","author":"Sorkio","year":"2018","journal-title":"Biomaterials"},{"key":"2022062819311138600_cvab232-B118","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/bit.26349","article-title":"Bone tissue bioprinting for craniofacial reconstruction","volume":"114","author":"Datta","year":"2017","journal-title":"Biotechnol Bioeng"},{"key":"2022062819311138600_cvab232-B119","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tins.2017.11.001","article-title":"Bioprinting for neural tissue engineering","volume":"41","author":"Knowlton","year":"2018","journal-title":"Trends Neurosci"},{"key":"2022062819311138600_cvab232-B120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biomaterials.2018.08.006","article-title":"Multiscale bioprinting of vascularized models","volume":"198","author":"Miri","year":"2019","journal-title":"Biomaterials"},{"key":"2022062819311138600_cvab232-B121","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1126\/science.aav9750","article-title":"Multivascular networks and functional intravascular topologies within biocompatible hydrogels","volume":"364","author":"Grigoryan","year":"2019","journal-title":"Science"},{"key":"2022062819311138600_cvab232-B122","doi-asserted-by":"crossref","first-page":"e1805530","DOI":"10.1002\/smll.201805530","article-title":"3D bioprinting in skeletal muscle tissue engineering","volume":"15","author":"Ostrovidov","year":"2019","journal-title":"Small"},{"key":"2022062819311138600_cvab232-B123","doi-asserted-by":"crossref","first-page":"12307","DOI":"10.1038\/s41598-018-29968-5","article-title":"3D bioprinted human skeletal muscle constructs for muscle function restoration","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"2022062819311138600_cvab232-B124","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1016\/j.biomaterials.2012.04.050","article-title":"A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering","volume":"33","author":"Billiet","year":"2012","journal-title":"Biomaterials"},{"key":"2022062819311138600_cvab232-B125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/jfb2030119","article-title":"Controlled positioning of cells in biomaterials-approaches towards 3D tissue printing","volume":"2","author":"W\u00fcst","year":"2011","journal-title":"J Funct Biomater"},{"key":"2022062819311138600_cvab232-B126","doi-asserted-by":"crossref","first-page":"e1901648","DOI":"10.1002\/adhm.201901648","article-title":"Advances in extrusion 3D bioprinting: a focus on multicomponent hydrogel-based bioinks","volume":"9","author":"Cui","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"2022062819311138600_cvab232-B127","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.actbio.2017.05.025","article-title":"3D bioprinting for drug discovery and development in pharmaceutics","volume":"57","author":"Peng","year":"2017","journal-title":"Acta Biomater"},{"key":"2022062819311138600_cvab232-B128","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/sctm.17-0148","article-title":"Concise review: bioprinting of stem cells for transplantable tissue fabrication","volume":"6","author":"Leberfinger","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"2022062819311138600_cvab232-B129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.actbio.2018.02.007","article-title":"3D bioprinted functional and contractile cardiac tissue constructs","volume":"70","author":"Wang","year":"2018","journal-title":"Acta Biomater"},{"key":"2022062819311138600_cvab232-B130","doi-asserted-by":"crossref","first-page":"010402","DOI":"10.1063\/1.5144525","article-title":"Bioengineering of the heart","volume":"4","author":"Redaelli","year":"2020","journal-title":"APL Bioeng"},{"key":"2022062819311138600_cvab232-B131","first-page":"50039","article-title":"Capillary force lithography for cardiac tissue engineering","author":"Macadangdang","year":"2014","journal-title":"J Vis Exp"},{"key":"2022062819311138600_cvab232-B132","doi-asserted-by":"crossref","first-page":"e0205514","DOI":"10.1371\/journal.pone.0205514","article-title":"Hippo signaling pathway is altered in Duchenne muscular dystrophy","volume":"13","author":"Vita","year":"2018","journal-title":"PLoS One"},{"key":"2022062819311138600_cvab232-B133","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1038\/s41598-021-89603-8","article-title":"Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes","volume":"11","author":"Yasutake","year":"2021","journal-title":"Sci Rep"},{"key":"2022062819311138600_cvab232-B134","doi-asserted-by":"crossref","first-page":"280","DOI":"10.18063\/ijb.v6i4.280","article-title":"Applications of 3D bioprinted-induced pluripotent stem cells in healthcare","volume":"6","author":"Soman","year":"2020","journal-title":"Int J Bioprint"},{"key":"2022062819311138600_cvab232-B135","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700175","article-title":"3D bioprinting human induced pluripotent stem cell constructs for in situ cell proliferation and successive multilineage differentiation","volume":"6","author":"Gu","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"2022062819311138600_cvab232-B136","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1096\/fasebj.11.8.9240969","article-title":"Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system","volume":"11","author":"Eschenhagen","year":"1997","journal-title":"FASEB J"},{"key":"2022062819311138600_cvab232-B137","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1096\/fasebj.14.5.669","article-title":"Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement","volume":"14","author":"Fink","year":"2000","journal-title":"FASEB J"},{"key":"2022062819311138600_cvab232-B138","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm1394","article-title":"Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts","volume":"12","author":"Zimmermann","year":"2006","journal-title":"Nat Med"},{"key":"2022062819311138600_cvab232-B139","doi-asserted-by":"crossref","first-page":"I16","DOI":"10.1161\/CIRCULATIONAHA.106.679688","article-title":"Development of a biological ventricular assist device: preliminary data from a small animal model","volume":"116","author":"Yildirim","year":"2007","journal-title":"Circulation"},{"key":"2022062819311138600_cvab232-B140","doi-asserted-by":"crossref","first-page":"I151","DOI":"10.1161\/01.cir.0000032876.55215.10","article-title":"Cardiac grafting of engineered heart tissue in syngenic rats","volume":"106","author":"Zimmermann","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"2022062819311138600_cvab232-B141","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nprot.2017.033","article-title":"Differentiation of cardiomyocytes and generation of human engineered heart tissue","volume":"12","author":"Breckwoldt","year":"2017","journal-title":"Nat Protoc"},{"key":"2022062819311138600_cvab232-B142","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.107.162982","article-title":"Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin\/utrophin expression","volume":"102","author":"Bostick","year":"2008","journal-title":"Circ Res"},{"key":"2022062819311138600_cvab232-B143","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","article-title":"Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering","volume":"23","author":"Maffioletti","year":"2018","journal-title":"Cell Rep"},{"key":"2022062819311138600_cvab232-B144","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1242\/dev.150201","article-title":"The hope and the hype of organoid research","volume":"144","author":"Huch","year":"2017","journal-title":"Development"},{"key":"2022062819311138600_cvab232-B145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"key":"2022062819311138600_cvab232-B146","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"2022062819311138600_cvab232-B147","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"2022062819311138600_cvab232-B148","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nm.2470","article-title":"Isolation and in vitro expansion of human colonic stem cells","volume":"17","author":"Jung","year":"2011","journal-title":"Nat Med"},{"key":"2022062819311138600_cvab232-B149","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"2022062819311138600_cvab232-B150","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","article-title":"Cardioids reveal self-organizing principles of human cardiogenesis","volume":"184","author":"Hofbauer","year":"2021","journal-title":"Cell"},{"key":"2022062819311138600_cvab232-B151","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nmat2344","article-title":"Physical approaches to biomaterial design","volume":"8","author":"Mitragotri","year":"2009","journal-title":"Nat Mater"},{"key":"2022062819311138600_cvab232-B152","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.biomaterials.2017.07.021","article-title":"Inspiration from heart development: biomimetic development of functional human cardiac organoids","volume":"142","author":"Richards","year":"2017","journal-title":"Biomaterials"},{"key":"2022062819311138600_cvab232-B153","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2013.137","article-title":"Microfabrication of human organs-on-chips","volume":"8","author":"Huh","year":"2013","journal-title":"Nat Protoc"},{"key":"2022062819311138600_cvab232-B154","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2022062819311138600_cvab232-B155","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1021\/ac980656z","article-title":"Rapid prototyping of microfluidic systems in poly(dimethylsiloxane)","volume":"70","author":"Duffy","year":"1998","journal-title":"Anal Chem"},{"key":"2022062819311138600_cvab232-B156","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bios.2014.07.029","article-title":"Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices","volume":"63","author":"Halldorsson","year":"2015","journal-title":"Biosens Bioelectron"},{"key":"2022062819311138600_cvab232-B157","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1039\/c3lc50252j","article-title":"Hydrogel-coated microfluidic channels for cardiomyocyte culture","volume":"13","author":"Annabi","year":"2013","journal-title":"Lab Chip"},{"key":"2022062819311138600_cvab232-B158","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/adma.201503255","article-title":"Highly elastic and conductive human-based protein hybrid hydrogels","volume":"28","author":"Annabi","year":"2016","journal-title":"Adv Mater"},{"key":"2022062819311138600_cvab232-B159","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1039\/c1lc20557a","article-title":"Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip","volume":"11","author":"Grosberg","year":"2011","journal-title":"Lab Chip"},{"key":"2022062819311138600_cvab232-B160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/aivt.2016.0002","article-title":"Cardiovascular organ-on-a-chip platforms for drug discovery and development","volume":"2","author":"Ribas","year":"2016","journal-title":"Appl In Vitro Toxicol"},{"key":"2022062819311138600_cvab232-B161","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1039\/c3lc50350j","article-title":"Microfluidic heart on a chip for higher throughput pharmacological studies","volume":"13","author":"Agarwal","year":"2013","journal-title":"Lab Chip"},{"key":"2022062819311138600_cvab232-B162","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1039\/C3LC51123E","article-title":"Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle","volume":"14","author":"Xiao","year":"2014","journal-title":"Lab Chip"},{"key":"2022062819311138600_cvab232-B163","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1038\/s41598-017-08879-x","article-title":"Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform","volume":"7","author":"Skardal","year":"2017","journal-title":"Sci Rep"},{"key":"2022062819311138600_cvab232-B164","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fphys.2020.00368","article-title":"Advances in stem cell modeling of dystrophin-associated disease: implications for the wider world of dilated cardiomyopathy","volume":"11","author":"Pioner","year":"2020","journal-title":"Front Physiol"},{"key":"2022062819311138600_cvab232-B165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/genes11070765","article-title":"Cardiac","volume":"11","author":"Lim","year":"2020","journal-title":"Genes (Basel)"},{"key":"2022062819311138600_cvab232-B166","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/acs.analchem.8b05293","article-title":"Recent advances in body-on-a-chip systems","volume":"91","author":"Sung","year":"2019","journal-title":"Anal Chem"},{"key":"2022062819311138600_cvab232-B167","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2010.06.003","article-title":"Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells","volume":"7","author":"Seki","year":"2010","journal-title":"Cell Stem Cell"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvab232\/39456008\/cvab232.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/118\/8\/1872\/44276790\/cvab232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/118\/8\/1872\/44276790\/cvab232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T19:33:19Z","timestamp":1656444799000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/118\/8\/1872\/6319721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":167,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,12]]},"published-print":{"date-parts":[[2022,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvab232","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,15]]},"published":{"date-parts":[[2021,7,12]]}}}